Subchondroplasty for Treatment of Bone Marrow Edema in the Foot and Ankle
1 other identifier
observational
20
1 country
1
Brief Summary
The subchondroplasty procedure has been used to treat bone marrow edema mostly located in the periarticular region of the knee. In the past few years, it has expanded its use in the foot and ankle. There has, however, been very minimal research documented on its utilization in that area. This study aims to prospectively evaluate the course of treatment and outcomes of painful bone marrow lesions in these associated podiatric circumstances using subchondroplasty. It is hypothesized that use of calcium phosphate bone substitute in the foot and ankle to treat bone marrow edema will have more favorable short and long-term outcomes than joint destructive and joint sparing procedures more commonly performed for treatment in the past.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2019
CompletedFirst Posted
Study publicly available on registry
April 19, 2019
CompletedStudy Start
First participant enrolled
June 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2024
CompletedMay 4, 2025
September 1, 2024
3.5 years
April 17, 2019
May 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Visual Analog Scale for pain
Best 0-10 worst - Continuous scale to measure current pain level
0-12 months
Subchondroplasty Patient Satisfaction Survey
Worst 0-5 best. 5-item scale to measure patient satisfaction after subchondroplasty procedure
0-12 months
The American Orthopedic Foot and Ankle Score (AOFAS)
Worst 0-100 best
0-12 months
Study Arms (1)
Subchondroplasty in treating bone marrow edema
These patients will have calcium phosphate mineral compound injected into the bone marrow lesions.
Interventions
Calcium phosphate mineral compound injected into the bone marrow lesions
Eligibility Criteria
Patients with bone marrow edema diagnosed on MRI who elect to receive subchondroplasty procedure
You may qualify if:
- Bone marrow edema diagnosed on MRI
- Pain in the foot and ankle due to the presence of bone marrow edema
- Failed 3 months of conservative treatment
You may not qualify if:
- Patient \<18 years of age
- Presence of osteomyelitis of poor surgical candidates due to comorbidities such as diabetics with an HbA1c of \>8%
- Patient with previous foot and ankle surgeries that may interfere with future outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Geisinger Community Medical Center
Scranton, Pennsylvania, 18510, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Ellianne Nasser, MD
Geisinger Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Staff Physician
Study Record Dates
First Submitted
April 17, 2019
First Posted
April 19, 2019
Study Start
June 4, 2021
Primary Completion
December 19, 2024
Study Completion
December 19, 2024
Last Updated
May 4, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share